Polar Capital Holdings »

Rapport Therapeutics shares owned by Polar Capital Holdings

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Polar Capital Holdings from 13F filings

Historical chart of Polar Capital Holdings investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Polar Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Polar Capital Holdings

Quarter filed Position value Share count Share price at filing
2025-09-30 $28M 939k 29.70

More positions owned by Polar Capital Holdings

NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Microsoft Corporation Call Option (MSFT)
Cloudflare Cl A Com (NET)
Lam Research Corp Com New (LRCX)
Kla Corp Com New (KLAC)
Seagate Technology Hldngs Pl Ord Shs (STX)
Renaissance Re Holdings Ltd Cmn (RNR)
Apple (AAPL)
Corning Incorporated (GLW)
Arch Cap Group Ord (ACGL)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Credo Technology Group Holdi Ordinary Shares (CRDO)

View all positions for Polar Capital Holdings

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
Sofinnova Ventures
Johnson & Johnson
Vanguard Group
BlackRock
Baker Bros. Advisors
Siren
Trv Gp Vi
Vestal Point Capital
Polar Capital Holdings

View all funds holding Rapport Therapeutics